Yiyi Weng

Shanghai First People's Hospital

Papers

1

Total Citations

6

H-Index

1

About

Dr. Yiyi Weng is a pioneering urologic surgeon whose research focuses on advancing minimally invasive surgical techniques for prostate cancer treatment. Her most significant contribution lies in the comparative assessment of robot-assisted radical prostatectomy (RARP) against conventional laparoscopic approaches. In her landmark 2022 retrospective cohort study, Dr. Weng demonstrated that RARP offers superior perioperative outcomes, including reduced blood loss and faster recovery times, while maintaining comparable oncologic efficacy. This work has garnered 6 citations and provides critical evidence supporting the adoption of robotic platforms in urologic oncology. Dr. Weng’s research addresses a pressing clinical need: optimizing surgical precision while minimizing patient morbidity. Her findings have helped establish RARP as a gold-standard technique, influencing surgical protocols in high-volume centers worldwide. By rigorously evaluating single-center outcomes, she has laid the groundwork for larger multicenter trials. Dr. Weng’s dedication to evidence-based surgical innovation continues to shape the future of prostate cancer care, making her a rising authority in the field of robotic urologic surgery.

Research Focus

Key Achievements

1
H-Index
1
Papers
6
Total Citations
6
Avg Citations/Paper
🏆 Most Cited Paper
Robot-assisted radical resection in prostate cancer comparative assessment with conventional laparoscopic prostatectomy: a retrospective comparative cohort study with single-center experience
6 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 2
🏛 Institutions: Shanghai First People's Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago